SINGAPORE - Against the backdrop of positive vaccine developments and upbeat Chinese data, the benchmark Straits Times Index rebounded from the previous day's loss to close 0.29 per cent or 8.17 points higher at 2,814.12.
On the vaccine front, Moderna on Monday said it is filing for US and European emergency regulatory approval of its coronavirus vaccine so that it can be recommended for widespread use. The company said on Monday that it has signed agreements totalling about US$226 million to build and deliver nine vessels.
Advancers outnumbered decliners 250 to 197 for the day, with 2.35 billion securities worth S$1.34 billion changing hands.The Nikkei 225 Index gained 1.34 per cent or 353.92 points to end at 26,787.54; the benchmark Kospi closed 1.66 per cent or 42.91 points higher at 2,634.25.